Johnson & Johnson/ US4781601046 /

8/12/2022 8:34:11 PM	Chg. -0.95	Volume	Bid8:34:22 PM	Ask8:34:22 PM	Market Capitalization	Dividend Y.	P/E Ratio
166.21USD	-0.57%	414,667 Turnover: 68.87 mill.	165.50Bid Size: 114	166.23Ask Size: 335	439.44 bill.USD	2.51%	21.08

TeleTrader 12:54 AM J&J to stop selling talc-based baby powder in 2023

TeleTrader 7/19 J&J posts Q2 EPS of $1.8, dropping 23.4% YoY

TeleTrader 5/6 FDA limits J&J vaccine use due to blood clot risks

TeleTrader 4/19 J&J's Q1 sales up 5% YoY to $23.4B

TeleTrader 3/29 CDC confirms additional boosters for over-50s

TeleTrader 2/19 Johnson: Putin must know he would pay high price for invasion

GlobeNewswire 2/16 Top NoSQL Innovators Honored with ScyllaDB Awards

TeleTrader 2/8 Report: J&J quietly paused COVID vaccine production

TeleTrader 1/25 J&J Q4 EPS soars 172.3% to $1.77

TeleTrader 12/30/2021 J&J booster 85% effective against hospitalization in S. Africa

TeleTrader 12/27/2021 Switzerland approves J&J booster

TeleTrader 12/24/2021 S. Africa to start rollout of vaccine boosters today

TeleTrader 12/17/2021 J&J, Sputnik V, Sinopharm jabs weaker against Omicron - study

TeleTrader 12/16/2021 CDC recommends mRNA vaccines over J&J

GlobeNewswire 12/16/2021 Guardion Health Sciences Issues Letter to Shareholders

TeleTrader 12/16/2021 CDC to consider restricting J&J's COVID jab - report

TeleTrader 12/15/2021 EMA recommends J&J's booster dose for use in adults

GlobeNewswire 12/7/2021 Pensa Hires Kroger Veteran Mark Abernathy As Retail Market Lead

TeleTrader 12/5/2021 Walensky: FDA may streamline jab approval

TeleTrader 11/29/2021 J&J to evaluate its vaccine against Omicron variant

TeleTrader 11/26/2021 J&J testing vaccine against new strain

TeleTrader 11/24/2021 Canada gives full approval to J&J COVID vaccine

TeleTrader 11/22/2021 EMA evaluating J&J's booster shot application

TeleTrader 11/16/2021 Japan to ease quarantine rules for J&J recipients - report

TeleTrader 11/12/2021 J&J confirms plans to split into two companies